Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 18:45:59 UTC 2023
by
admin
on
Sat Dec 16 18:45:59 UTC 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | ALLOGENIC HUMAN |
| Source Materials Parent | |
| Part | BLOOD |
| Fraction Name | CD34+ enriched Hematopoietic Stem/Progenitor Cell from HLA matched donor |
| Record UNII |
CT5FM8JN3S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
12263
Created by
admin on Sat Dec 16 18:45:59 UTC 2023 , Edited by admin on Sat Dec 16 18:45:59 UTC 2023
|
PRIMARY | |||
|
CT5FM8JN3S
Created by
admin on Sat Dec 16 18:45:59 UTC 2023 , Edited by admin on Sat Dec 16 18:45:59 UTC 2023
|
PRIMARY | |||
|
C180524
Created by
admin on Sat Dec 16 18:45:59 UTC 2023 , Edited by admin on Sat Dec 16 18:45:59 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
VOR33 will be infused into patients with acute myeloid leukemia (AML) undergoing hematopoietic cell transplant who are known to be at high-risk for leukemia relapse and mortality post transplantation.
|